| Revenue | — | — | — |
| Net product revenue | 273.87a | 176.07a | 79.23a |
| Service revenue | 167.67a | 65.55a | 14.23a |
| Total revenue | 441.54a | 241.62a | 93.46a |
| Cost of revenue | — | — | — |
| Cost of net product revenue | -58.35a | -41.02a | -16.97a |
| Cost of service revenue | -121.11a | -46.52a | -11.22a |
| Total cost of revenue | -179.46a | -87.53a | -28.19a |
| Gross profit | 262.08a | 154.09a | 65.27a |
| Operating expenses | — | — | — |
| Research, development and clinical trials | -55.97a | -36.06a | -26.81a |
| Acquired in-process research and development expenses | 0a | -27.21a | 0a |
| Selling, general and administrative | -168.62a | -119.55a | -69.9a |
| Total operating expenses | -224.59a | -182.82a | -96.71a |
| Income (loss) from operations | 37.5a | -28.73a | -31.44a |
| Other income (expense) | — | — | — |
| Interest expense | -14.41a | -10.79a | -3.73a |
| Interest income and other income (expense), net | 12.69a | 12.85a | -1a |
| Total other income (expense), net | -1.72a | 2.06a | -4.73a |
| Income (loss) before income taxes | 35.78a | -26.67a | -36.17a |
| (Provision) benefit for income taxes | -0.32a | -1.64a | -0.07a |
| Net income (loss) | 35.46a | -25.03a | -36.23a |